PBS Website Update - 1 April 2020

The Schedule of Pharmaceutical Benefits was updated on 1 April 2020 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website

• Drugs subject to Price Disclosure - 1 April 2020
• Formulary Allocations - 1 April 2020
• First New Brand Price Reductions - 1 April 2020
• Ex-manufacturer price - 1 April 2020
• General Statement for Drugs for the Treatment of Hepatitis C - 1 April 2020
• Expansion of Pharmaceutical Benefits Scheme Continued Dispensing Arrangements Covid-19 - 31 March 2020
• 1 April 2020 Price Disclosure Confirmed Prices - 31 March 2020
• Biosimilar pegfilgrastim on the PBS - information for health professionals and patients - 24 March 2020
• PBAC Public Summary Documents - November 2019 Meeting (first time rejections and deferrals) - 20 March 2020
• Revised PBS listings for Antibiotic use from 1 April 2020 - 20 March 2020
• PBS and RPBS Section 85 Date of Supply Data - 19 March 2020
• Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 18 March 2020
• Health Products Portal Industry Webinars - 17 March 2020
• Price Disclosure Reductions for 2020 April Cycle - 13 March 2020
• Final Terms of Reference and Public consultation to the post-market review of medicines for smoking cessation - 13 March 2020
• Health Products Portal - Terms and Conditions - 11 March 2020
• PBAC Public Summary Documents - November 2019 meeting - 6 March 2020
• Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents – 6 March 2020
• Standardised redactions to Public Summary Documents – nominations open for participation in the final trial, and implementation from July 2020 - 5 March 2020